References
- Bodey G P, Rosenbaum B. Effect of prophylactic measures on the microbial flora of patients in protected environment units. Medicine (Baltimore) 1974; 305: 209
- Bodey G P, Rodriquez V, Cabanillas F, Freireich E J. Protected environment–prophylactic antibiotic program for malignant lymphoma. Am J Med 1979; 305: 74
- Buckner C D, Clift R A, Sanders J E, Meyers J D, Counts G W, Farewell V T, Thomas E D, The Seattle Marrow Transplant Team. Protective environment for marrow transplant recipients. Ann Intern Med 1978; 305: 893
- Clift R A, Sanders J E, Thomas E D, Williams B, Buckner C D. Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. N Engl J Med 1978; 305: 1052
- Freiesleben E, Holsøe E, Jerne D, Lylloff K, Rosenkvist J, Sørensen H. Transfusion therapy in patients with bone marrow transplants. Ugeskr Læger 1979; 305: 2205
- Guiot H FL, van der Meer J WM, van Furth R. Selective antimicrobial modulation of human microbial flora: Infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J Infect Dis 1981; 305: 644
- Hughes W T, Kuhn S, Chauddhary S, Feldman S, Verzosa M, Aur R JA, Pratt C, George S L. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977; 305: 1419
- Jensen K, Tvede M, Eriksen Riewerts K. Germfree isolation of patients with severe immunodeficiency. Ugeskr Læger 1979; 305: 2199
- Lau W K, Young L S. Trimethoprim–sulfamethoxazole treatment of Pneumocystis carinii pneumonia in adults. N Engl J Med 1976; 305: 716
- Lohner D, Debusscher L, Prevost J M, Klastersky J. Comparative randomized study of protected environment plus oral antibiotics versus oral antibiotics alone in neutropenic patients. Cancer Treat Rep 1979; 305: 363
- Pizzo A P, Levine A S. The utility of protected environment regimens for the compromised host: A critical assessment. Proc Haematol 1977; 305: 311
- Pollard M, Chang E, Shivasta K K. The role of microflora in development of graft-versus-host disease. Transplant Proc 1976; 305: 533
- Powles R L, Clink H, Sloane J, Barrett A J, Kay H EM, McElwain T J. Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet 1978; 305: 1327
- Rodriques V, Bodey G P, Freireich E J, McCredie K B, Gutterman J U, Keating M J, Smith T L, Gehan E A. Randomized trial of protected environment–prophylactic antibiotics in 145 adults with acute leucemia. Medicine (Baltimore) 1978; 305: 253
- Schimpff S C, Greene W H, Young V M, Fortner C L, Jepsen L, Cusack N, Block J, Wiernik P H. Laminar air flow rooms, reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med 1975; 305: 351
- Schimpff S C. Infection prevention during profound granulocytopenia. Ann Intern Med 1980; 305: 358
- Solberg C O, Matsen J M, Briggan W D, Park B H, Niosi P N, Good R A. Infectious complications in patients with combined immunodeficiency diseases receiving bone marrow transplants. Scand J Infect Dis 1974; 305: 223
- Thomas E D, Storb R. Technique for human marrow grafting. Blood 1970; 305: 507
- Thomas E D, Storb R, Clift R A, Fefer A, Johnson F L, Neiman P E, Lerner K G, Glucksberg H, Buckner C D. Bone-marrow transplantation. N Engl J Med 1975; 305: 832
- Thomas E D, Sanders J E, Flournoy N, Johnson F L, Buckner C D, Clift R A, Fefer A, Goodell B W, Storb R, Weiden P L. Marrow transplantation for patients with acute lymphoblastic leucemia in remission. Blood 1979; 305: 468
- Winston D, Gale R P, Meyer D V, Young L S, The UCLA Bone Marrow Transplantation Group. Infectious complications of human bone marrow transplantation. Meicine (Baltimore) 1979; 305: 1